<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: cancer center</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'cancer center'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22cancer+center%22&t=%22cancer+center%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:11:32 +0100</lastBuildDate>
        <item>
            <title>Hospital CEO Is Diagnosed With Cancer While Building A New Cancer Center</title>
            <link>http://www.medworm.com/index.php?rid=5181800&amp;cid=t_140381_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fhospital-ceo-is-diagnosed-with-cancer-while-building-a-new-cancer-center%2F2011.09.01</link>
            <description>Pat Elliott, me and a HUGE cactus at Banner MD Anderson!
I am just back from the Phoenix-metro area. It’s now the 5th largest in the United States and despite home foreclosures, there is still a feeling of growth in many areas. Gilbert, a nearby suburb, has expanded to over 200,000 people and a growing major medical center. I spent several days interviewing patients and staff about the soon-to-open, Banner MD Anderson Cancer Center. The hope is that by bringing MD Anderson’s world-renowned expertise, clinical trials and processes to this new center, cancer care around Phoenix and the southwest will be improved. Look for my video interviews coming soon.
But, in the meantime, one interview stuck out for me; the one with the Banner Health President and CEO, Peter Fine. Peter is in his lat...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5181800</comments>
            <pubDate>Thu, 01 Sep 2011 16:00:00 +0100</pubDate>
            <guid isPermaLink="false">5181800</guid>        </item>
        <item>
            <title>Getting Your Medical Records for Free or Low Cost?</title>
            <link>http://www.medworm.com/index.php?rid=5159684&amp;cid=t_140381_136_f&amp;fid=39025&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Feverythingchangesbook%2F%7E3%2F4ayIcMmnxs4%2Fmedical-records-request-free</link>
            <description>By Jackie Blachman-Forshay and Kairol Rosenthal
As a patient, you have the right to access your own medical records for a “reasonable” fee, according to federal HIPAA laws.  Most doctors’ offices and hospitals charge copying fees, which range widely in price, and add up if you have a thick chart. Here are a few ways to get your records for free or at reduced cost:
1. Make friends with the office staff. Receptionists and nurses deserve to be treated well for all the work they do for us and will often reciprocate our kindness.  Some may copy your records for free.  Be sure to say “thank you!”
2. Ask for your records a little at a time. Did your doc just read your lab report over the phone? Ask them to drop a copy in the mail.  Did they explain your pathology report during your ...</description>
            <author>Everything Changes</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5159684</comments>
            <pubDate>Tue, 23 Aug 2011 15:05:26 +0100</pubDate>
            <guid isPermaLink="false">5159684</guid>        </item>
        <item>
            <title>Blunting the Activity of Protein Abcc10 May Help Counter Taxane Drug Resistance In Ovarian Cancer</title>
            <link>http://www.medworm.com/index.php?rid=4829221&amp;cid=t_140381_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2011%2F05%2F16%2Fblunting-the-activity-of-protein-abcc10-may-help-counter-taxane-drug-resistance-in-ovarian-cancer%2F</link>
            <description>New findings by Fox Chase Cancer Center researchers identify one protein, Abcc10, as being intimately involved in resistance to certain drugs used to treat breast, ovarian, lung, and other cancers. The results suggest that blunting the activity of Abcc10 might help counter resistance and extend the effectiveness of these anticancer drugs. Today’s anticancer drugs often [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4829221</comments>
            <pubDate>Tue, 17 May 2011 04:02:49 +0100</pubDate>
            <guid isPermaLink="false">4829221</guid>        </item>
        <item>
            <title>InformationWeek’s Healthcare CIO 25</title>
            <link>http://www.medworm.com/index.php?rid=4684478&amp;cid=t_140381_113_f&amp;fid=34625&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FNeilVerselsHealthcareItBlog%2F%7E3%2F8o9rFUIBgWw%2F</link>
            <description>I&amp;#8217;ve been starting to contribute a bit to InformationWeek. One of my first projects was interviewing five of the publication&amp;#8217;s first-ever list of 25 leading healthcare CIOs. I wrote the profiles on Stephanie Reel of Johns Hopkins Health System, Lynn Vogel of MD Anderson Cancer Center, Dr. Paul Tang of Palo Alto Medical Foundation, Bill Spooner of Sharp HealthCare and Craig Luigart of the Veterans Health Administration.
The link above contains the full text, or you can download an abbreviated &amp;#8220;print&amp;#8221; edition in the form of the March InformationWeek Healthcare e-zine here.
It&amp;#8217;s not the first time I&amp;#8217;ve written about CIOs for a national publication not specific to healthcare, but I&amp;#8217;m pretty proud of reaching the pages of InformationWeek.
Meanwhile, che...</description>
            <author>Neil Versel's Healthcare IT Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4684478</comments>
            <pubDate>Wed, 06 Apr 2011 04:46:38 +0100</pubDate>
            <guid isPermaLink="false">4684478</guid>        </item>
        <item>
            <title>When A World-Class Medical Institution Saves You Yet Fails You</title>
            <link>http://www.medworm.com/index.php?rid=4455264&amp;cid=t_140381_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fwhen-a-world-class-medical-institution-saves-you-yet-fails-you%2F2011.02.09</link>
            <description>Let me start by saying I really like MD Anderson Cancer Center. There is a lot to like. Take their tag line for example: “Making care history.” If anyone finds a cure for this cancer or that cancer, MD Anderson will have a hand in it, I&amp;#8217;m sure. Hospitals could also learn a thing or two about the meaning of comprehensive care, clinical integration, and customer service from MD Anderson is well.
I have another reason why I like MD Anderson so well: They saved my wife’s life. You see, she was diagnosed back in November of 2004 with stage four non-small cell lung cancer (NSCLC). As anyone familiar with lung care knows, lung cancer is a very tough adversary. It’s an even tougher adversary when your insurance company insists that your local community hospital and oncologists are ...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4455264</comments>
            <pubDate>Wed, 09 Feb 2011 18:00:04 +0100</pubDate>
            <guid isPermaLink="false">4455264</guid>        </item>
        <item>
            <title>A Window Into Cancer Research</title>
            <link>http://www.medworm.com/index.php?rid=4377569&amp;cid=t_140381_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fa-window-into-cancer-research%2F2011.01.20</link>
            <description>Exciting Time with World Renowned Experts from Patient Power® on Vimeo.

			
			*This blog post was originally published at Andrew's Blog* (Source: Better Health)</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4377569</comments>
            <pubDate>Thu, 20 Jan 2011 20:00:10 +0100</pubDate>
            <guid isPermaLink="false">4377569</guid>        </item>
        <item>
            <title>Peptide Being Tested for Atherosclerosis Inhibits Ovarian Cancer Growth; Clinical Trial Planned</title>
            <link>http://www.medworm.com/index.php?rid=4134151&amp;cid=t_140381_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2010%2F11%2F02%2Fpeptide-being-tested-for-atherosclerosis-inhibits-ovarian-cancer-growth-clinical-trial-planned%2F</link>
            <description>A drug in testing to treat atherosclerosis significantly inhibited growth of ovarian cancer in both human cell lines and mouse models, marking the first such report of a peptide being used to fight malignancies, according to a study by researchers at UCLA’s Jonsson Comprehensive Cancer Center. A drug in testing to treat atherosclerosis significantly inhibited [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4134151</comments>
            <pubDate>Tue, 02 Nov 2010 22:59:25 +0100</pubDate>
            <guid isPermaLink="false">4134151</guid>        </item>
        <item>
            <title>Girls with Stage I Ovarian Germ-Cell Tumors Can Safely Skip Chemotherapy Until Recurrence</title>
            <link>http://www.medworm.com/index.php?rid=4122024&amp;cid=t_140381_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2010%2F10%2F31%2Fgirls-with-stage-i-ovarian-germ-cell-tumors-can-safely-skip-chemotherapy-until-recurrence%2F</link>
            <description>Researchers from Dana-Farber/Children&amp;#8217;s Hospital Cancer Center found that as many as 50 percent of young girls treated for germ-cell ovarian tumors may be safely spared chemotherapy using a &amp;#8220;watch and wait&amp;#8221; strategy to determine whether follow-up treatment is needed. Researchers from Dana-Farber/Children&amp;#8217;s Hospital Cancer Center (DF/CHCC) found that as many as 50 percent of young girls [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4122024</comments>
            <pubDate>Sun, 31 Oct 2010 22:23:31 +0100</pubDate>
            <guid isPermaLink="false">4122024</guid>        </item>
        <item>
            <title>Experts Urge Cancer Patients To Exercise More</title>
            <link>http://www.medworm.com/index.php?rid=3656794&amp;cid=t_140381_83_f&amp;fid=34856&amp;url=http%3A%2F%2Finsidesurgery.com%2F2010%2F06%2Fexperts-urge-cancer-patients-exercise%2F</link>
            <description>Breast cancer survivor Marika Holmgren, University of Pennsylvania epidemiologist Kathryn Schmitz, PhD, and Albert Einstein Cancer Center Director of Psychosocial Oncology Alyson Moadel, PhD discuss the benefits and strategies around exercising during and after your cancer treatment. (Source: Inside Surgery)</description>
            <author>Inside Surgery</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3656794</comments>
            <pubDate>Sat, 12 Jun 2010 18:55:09 +0100</pubDate>
            <guid isPermaLink="false">3656794</guid>        </item>
        <item>
            <title>Leaders of Discredited Financial Rating Agencies as Leaders of Health Care</title>
            <link>http://www.medworm.com/index.php?rid=3552193&amp;cid=t_140381_87_f&amp;fid=34765&amp;url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2010%2F05%2Fleaders-of-discredited-financial-rating.html</link>
            <description>This is the latest in our informal series on the cross-linkages between the thinking and leadership that lead to the global financial collapse/ great recession and that current in health care.&amp;nbsp; Last month, a US Senate sub-committee held hearings on the role of the rating agencies, actually for-profit corporations that evaluated securities, including derivatives, in the collapse.&amp;nbsp; The Fundamentally Conflicted Rating AgenciesTo briefly provide some background, these agencies were hired by the firms that created these securities to evaluate them.&amp;nbsp; Because the securities were complex, they were hard for investors to evaluate.&amp;nbsp; Investors had become used to using the rating agencies' evaluations as benchmarks for the quality and riskiness of complex securities.&amp;nbsp; Many did...</description>
            <author>Health Care Renewal</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3552193</comments>
            <pubDate>Mon, 10 May 2010 20:45:00 +0100</pubDate>
            <guid isPermaLink="false">3552193</guid>        </item>
        <item>
            <title>On the Path to Early Detection:  Fox Chase &amp; Sloan-Kettering Researchers Identify Early Ovarian Cancers</title>
            <link>http://www.medworm.com/index.php?rid=3508396&amp;cid=t_140381_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2010%2F04%2F26%2Fon-the-path-to-early-detection-fox-chase-sloan-kettering-researchers-identify-early-ovarian-cancers%2F</link>
            <description>Researchers at the Fox Chase Cancer Center and the Memorial Sloan-Kettering Cancer Center discover early tumors and precancerous lesions in cysts that fold into the ovary from its surface, called inclusion cysts. “This is the first study giving very strong evidence that a substantial number of ovarian cancers arise in inclusion cysts and that there [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3508396</comments>
            <pubDate>Tue, 27 Apr 2010 04:01:54 +0100</pubDate>
            <guid isPermaLink="false">3508396</guid>        </item>
        <item>
            <title>Pittsburgh Event on Tuesday, April 20th</title>
            <link>http://www.medworm.com/index.php?rid=3449103&amp;cid=t_140381_136_f&amp;fid=39025&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Feverythingchangesbook%2F%7E3%2Fj1sGBHWXGE8%2Fpittsburgh-young-adult-cancer</link>
            <description>Calling all young adult cancer yinzers.  Join me, along with Charissa Hamilton-Gribenas, founder of BRICKS for Young Adults, for an evening of coffee and conversation.  Momentum is growing among the young adult cancer community in Pittsburgh. This will be a chance to hang out in a casual, non-clinical atmosphere to connect and talk about living young with cancer.

Pittsburgh Young Adult Cancer Event
Tuesday, April 20
7pm
Coffee Tree Roasters &amp;#8211; Shadyside
5524 Walnut Street
Need more info? 773-426-8081 


Plus, we&amp;#8217;ll be handing out free copies of the new BRICKS for Young Adults, a resource guide for young cancer patients in Pittsburgh. (Source: Everything Changes)</description>
            <author>Everything Changes</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3449103</comments>
            <pubDate>Wed, 07 Apr 2010 18:14:43 +0100</pubDate>
            <guid isPermaLink="false">3449103</guid>        </item>
        <item>
            <title>Some Women Undertreated for Breast Cancer After Receiving Mastectomy</title>
            <link>http://www.medworm.com/index.php?rid=3429114&amp;cid=t_140381_83_f&amp;fid=34856&amp;url=http%3A%2F%2Finsidesurgery.com%2F2010%2F04%2Fwomen-undertreated-breast-cancer-receiving-mastectomy%2F</link>
            <description>Dr. Reshma Jagsi and colleagues at the University of Michigan Comprehensive Cancer Center have published an article in the Journal of Clinical Oncology that shows that not all women who are candidates for radiation therapy after treatment of their breast cancer are in fact being offered it. (Source: Inside Surgery)</description>
            <author>Inside Surgery</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3429114</comments>
            <pubDate>Thu, 01 Apr 2010 04:06:14 +0100</pubDate>
            <guid isPermaLink="false">3429114</guid>        </item>
        <item>
            <title>Lifestyle Matters:  Dietary Factors Influence Ovarian Cancer Survival Rates</title>
            <link>http://www.medworm.com/index.php?rid=3339773&amp;cid=t_140381_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2010%2F03%2F06%2Fdietary-factors-influence-ovarian-cancer-survival-rates%2F</link>
            <description>University of Illinois at Chicago researchers identify relationship between healthy eating and prolonged ovarian cancer survival

A study published in the March 2010 issue of the Journal of the American Dietetic Association (JADA), is among the first to evaluate possible diet associations with ovarian cancer survival. Researchers from the University of Illinois at Chicago (UIC) determined [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3339773</comments>
            <pubDate>Sat, 06 Mar 2010 23:52:34 +0100</pubDate>
            <guid isPermaLink="false">3339773</guid>        </item>
        <item>
            <title>Genentech Announces Positive Results of Avastin Phase III Study in Women with Advanced Ovarian Cancer</title>
            <link>http://www.medworm.com/index.php?rid=3311889&amp;cid=t_140381_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2010%2F02%2F25%2Fgenentech-announces-positive-results-of-avastin-phase-iii-study-in-women-with-advanced-ovarian-cancer%2F</link>
            <description>Genentech announces positive results of Avastin Phase III study (GOG 218) in women with advanced ovarian cancer. The study showed that women who continued maintenance use of Avastin alone, after receiving Avastin in combination with chemotherapy, lived longer without the disease worsening compared to those who received chemotherapy alone. This is the first Phase [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3311889</comments>
            <pubDate>Thu, 25 Feb 2010 18:40:30 +0100</pubDate>
            <guid isPermaLink="false">3311889</guid>        </item>
        <item>
            <title>MAGP2 Gene Expression Signature: A Potential Ovarian Cancer Personalized Treatment Target</title>
            <link>http://www.medworm.com/index.php?rid=3071433&amp;cid=t_140381_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2009%2F12%2F08%2Fmagp2-gene-expression-signature-a-potential-ovarian-cancer-personalized-treatment-target%2F</link>
            <description>A multi-institutional study has identified a potential personalized treatment target for the most common form of ovarian cancer. In the December 8 issue of Cancer Cell, the research team describes finding that a gene called MAGP2 – not previously associated with any type of cancer – was overexpressed in papillary serous ovarian tumors of patients [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3071433</comments>
            <pubDate>Wed, 09 Dec 2009 03:17:59 +0100</pubDate>
            <guid isPermaLink="false">3071433</guid>        </item>
        <item>
            <title>Merck Seeks Medical Informatics Flunkie On The Cheap @ $30/hr</title>
            <link>http://www.medworm.com/index.php?rid=3026637&amp;cid=t_140381_87_f&amp;fid=34765&amp;url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2009%2F11%2Fmerck-seeks-medical-informatics-loser.html</link>
            <description>P { MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px } BODY { SCROLLBAR-ARROW-COLOR: #3f52b8; SCROLLBAR-DARKSHADOW-COLOR: #fafafa; SCROLLBAR-BASE-COLOR: #f7f7f7; SCROLLBAR-HIGHLIGHT-COLOR: #cecfce; SCROLLBAR-TRACK-COLOR: #fffbff } At the post &quot;Medical Informatics, Pharma, Health IT, and Golden Advice That Sits Sadly Unused&quot; and other posts I lamented the fact that the pharma sector (in deep decline due to scientific mediocrity, ill-qualified leadership, public image tarnished by scandal, and other reasons), as well as the Healthcare IT industry (now also racked by similar issues and undergoing a Senate investigation while its products are being found to show little benefit) neglected a scientific discipline that might actually help them achieve the goals of better products, better patient care, and str...</description>
            <author>Health Care Renewal</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3026637</comments>
            <pubDate>Tue, 17 Nov 2009 01:00:00 +0100</pubDate>
            <guid isPermaLink="false">3026637</guid>        </item>
        <item>
            <title>Merck Seeks Medical Informatics Dud On The Cheap @ $30/hr</title>
            <link>http://www.medworm.com/index.php?rid=3003702&amp;cid=t_140381_87_f&amp;fid=34765&amp;url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2009%2F11%2Fmerck-seeks-medical-informatics-loser.html</link>
            <description>P { MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px } BODY { SCROLLBAR-ARROW-COLOR: #3f52b8; SCROLLBAR-DARKSHADOW-COLOR: #fafafa; SCROLLBAR-BASE-COLOR: #f7f7f7; SCROLLBAR-HIGHLIGHT-COLOR: #cecfce; SCROLLBAR-TRACK-COLOR: #fffbff } At the post &quot;Medical Informatics, Pharma, Health IT, and Golden Advice That Sits Sadly Unused&quot; and other posts I lamented the fact that the pharma sector (in deep decline due to scientific mediocrity, ill-qualified leadership, public image tarnished by scandal, and other reasons), as well as the Healthcare IT industry (now also racked by similar issues and undergoing a Senate investigation while its products are being found to show little benefit) neglected a scientific discipline that might actually help them achieve the goals of better products, better patient care, and str...</description>
            <author>Health Care Renewal</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3003702</comments>
            <pubDate>Tue, 17 Nov 2009 01:00:00 +0100</pubDate>
            <guid isPermaLink="false">3003702</guid>        </item>
        <item>
            <title>Merck Seeks Medical Informatics Loser @ $30/hr</title>
            <link>http://www.medworm.com/index.php?rid=2999483&amp;cid=t_140381_87_f&amp;fid=34765&amp;url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2009%2F11%2Fmerck-seeks-medical-informatics-loser.html</link>
            <description>P { MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px } BODY { SCROLLBAR-ARROW-COLOR: #3f52b8; SCROLLBAR-DARKSHADOW-COLOR: #fafafa; SCROLLBAR-BASE-COLOR: #f7f7f7; SCROLLBAR-HIGHLIGHT-COLOR: #cecfce; SCROLLBAR-TRACK-COLOR: #fffbff } At the post &quot;Medical Informatics, Pharma, Health IT, and Golden Advice That Sits Sadly Unused&quot; and other posts I lamented the fact that the pharma sector (in deep decline due to scientific mediocrity, ill-qualified leadership, public image tarnished by scandal, and other reasons), as well as the Healthcare IT industry (now also racked by similar issues and undergoing a Senate investigation while its products are being found to show little benefit) neglected a scientific discipline that might actually help them achieve the goals of better products, better patient care, and str...</description>
            <author>Health Care Renewal</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2999483</comments>
            <pubDate>Tue, 17 Nov 2009 01:00:00 +0100</pubDate>
            <guid isPermaLink="false">2999483</guid>        </item>
        <item>
            <title>Modified Chemo Regime Increases Survival In Advanced Ovarian Cancer Patients But Adds Toxicity</title>
            <link>http://www.medworm.com/index.php?rid=2832371&amp;cid=t_140381_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2009%2F09%2F24%2Fmodified-chemo-regime-increases-survival-in-advanced-ovarian-cancer-patients-but-adds-toxicity%2F</link>
            <description>Women with advanced ovarian cancer lived longer and without their tumors growing after receiving a modified regimen of a standard chemotherapy drug combination, Japanese researchers reported last week. In a large phase III clinical trial, women who received carboplatin every 3 weeks and a reduced dose of paclitaxel (Taxol®) once a week for 3 weeks [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2832371</comments>
            <pubDate>Thu, 24 Sep 2009 20:44:57 +0100</pubDate>
            <guid isPermaLink="false">2832371</guid>        </item>
        <item>
            <title>Gloria Johns Was Told “Ovarian Cancer Patients Don’t Live Long Enough … To Have Support Groups;” She Proved Otherwise</title>
            <link>http://www.medworm.com/index.php?rid=2458453&amp;cid=t_140381_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2009%2F06%2F05%2Fshe-was-told-ovarian-cancer-patients-don%25e2%2580%2599t-live-long-enough-to-have-support-groups-gloria-johns-proved-otherwise%2F</link>
            <description>Every so often, you come across a story of hope, courage, and dogged perseverance that renews the spirit and lifts the soul.  Gloria Johns&amp;#8217; story is a classic example.  Gloria Johns is a 61 year old stage IV ovarian cancer survivor, who has battled the disease for nine years through five cancer recurrences.  When Gloria [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2458453</comments>
            <pubDate>Fri, 05 Jun 2009 21:47:52 +0100</pubDate>
            <guid isPermaLink="false">2458453</guid>        </item>
        <item>
            <title>Early Treatment of Recurrent Ovarian Cancer Based Upon Rising CA-125 Levels Does Not Increase Survival</title>
            <link>http://www.medworm.com/index.php?rid=2453074&amp;cid=t_140381_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2009%2F05%2F31%2Fearly-treatment-of-recurrent-ovarian-cancer-based-upon-rising-ca-125-levels-does-not-increase-survival%2F</link>
            <description>&amp;#8220;European researchers report [at the 2009 American Society of Clinical Oncology Annual Meeting being held in Orlando, Florida from May 29 through June 2nd] that starting treatment early for an ovarian cancer relapse based on CA125 blood levels alone does not improve overall survival, compared with delaying treatment until symptoms arise.&amp;#8221;


PLENARY PRESENTATION
SUNDAY, MAY 31, 1:45 [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2453074</comments>
            <pubDate>Sun, 31 May 2009 23:41:47 +0100</pubDate>
            <guid isPermaLink="false">2453074</guid>        </item>
        <item>
            <title>M.D. Anderson Study Predicts Dramatic Growth in Cancer Rates Among U.S. Elderly, Minorities</title>
            <link>http://www.medworm.com/index.php?rid=2381447&amp;cid=t_140381_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2009%2F04%2F30%2Fmd-anderson-study-predicts-dramatic-growth-in-cancer-rates-among-us-elderly-minorities%2F</link>
            <description>&amp;#8221; &amp;#8230; Over the next 20 years, the number of new cancer cases diagnosed annually in the United States will increase by 45 percent, from 1.6 million in 2010 to 2.3 million in 2030, with a dramatic spike in incidence predicted in the elderly and minority populations, according to research from The University of Texas [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2381447</comments>
            <pubDate>Fri, 01 May 2009 01:12:07 +0100</pubDate>
            <guid isPermaLink="false">2381447</guid>        </item>
        <item>
            <title>Personalized Medicine Helps Breast, Colorectal &amp; Ovarian Cancer Patients Survive</title>
            <link>http://www.medworm.com/index.php?rid=2349510&amp;cid=t_140381_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2009%2F04%2F20%2Fpersonalized-medicine-helps-breast-colorectal-ovarian-cancer-patients-survive%2F</link>
            <description>&amp;#8220;Cancer patients can survive longer under treatments based on their individual genetic profiles, according to a nationwide study released jointly today by Phoenix-area healthcare organizations. The study shows that molecular profiling of patients can identify specific treatments for individuals, helping keep their cancer in check for significantly longer periods, and in some cases even shrinking [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2349510</comments>
            <pubDate>Mon, 20 Apr 2009 20:33:00 +0100</pubDate>
            <guid isPermaLink="false">2349510</guid>        </item>
        <item>
            <title>True recovery begins after breast cancer treatment</title>
            <link>http://www.medworm.com/index.php?rid=2349545&amp;cid=t_140381_136_f&amp;fid=36032&amp;url=http%3A%2F%2Fwww.everydayhealth.com%2Fblog%2Flife-with-breast-cancer%2Ftrue-recovery-begins-after-breast-cancer-treatment%2F</link>
            <description>You completed your surgery or treatment, the surgical wounds have begun to fade and chemotherapy is a bad memory. Perhaps reconstruction is behind you and your hair is back on your head where it belongs. By all outward appearances you have begun to heal, or may even think you are fully healed from breast cancer. I’m sure your doctor, like mine is careful not to say that you are cured. My husband was told he was cured after his prostate cancer treatment and other cancers can be cured, but for breast cancer the word cured is not used. So we heal and we go on. Some of us can leave it behind and some of us carry the scars and overshadowing of cancer with us throughout our life.  Most of us I have discovered have fought breast cancer and won, but we haven’t healed.
Healing is a process. Wh...</description>
            <author>Life with Breast Cancer</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2349545</comments>
            <pubDate>Mon, 20 Apr 2009 17:11:17 +0100</pubDate>
            <guid isPermaLink="false">2349545</guid>        </item>
        <item>
            <title>Addition of Dasatinib (Sprycel) to Standard Chemo Cocktail May Enhance Effect in Certain Ovarian Cancers</title>
            <link>http://www.medworm.com/index.php?rid=2349512&amp;cid=t_140381_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2009%2F04%2F19%2Faddition-of-dasatinib-sprycel-to-standard-chemo-cocktail-may-enhance-effect-in-certain-ovarian-cancers%2F</link>
            <description>&amp;#8220;The addition of a chemotherapeutic drug for leukemia to a standard regimen of two other chemotherapy drugs appears to enhance the response of certain ovarian cancers to treatment, according to a pre-clinical study led by researchers in the Duke Comprehensive Cancer Center.  &amp;#8216;We know that a pathway called SRC is involved in cell proliferation in [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2349512</comments>
            <pubDate>Mon, 20 Apr 2009 06:42:05 +0100</pubDate>
            <guid isPermaLink="false">2349512</guid>        </item>
        <item>
            <title>Tumor-Promoting Protein COX-2 Is The Target Of First Joint Symposium Between AACR &amp; ASCO</title>
            <link>http://www.medworm.com/index.php?rid=2349513&amp;cid=t_140381_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2009%2F04%2F19%2Ftumor-promoting-protein-cox-2-is-the-target-of-first-joint-symposium-between-aacr-asco%2F</link>
            <description>&amp;#8220;An inflammatory protein implicated in a variety of cancers is the target of the first joint symposium between the nation&amp;#8217;s two premier cancer research organizations.  The presidents of the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO) organized the session focused on the COX-2 enzyme and cancer treatment Monday [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2349513</comments>
            <pubDate>Mon, 20 Apr 2009 05:03:52 +0100</pubDate>
            <guid isPermaLink="false">2349513</guid>        </item>
        <item>
            <title>Stanford Researchers Harness Nanoparticles To Track Cancer Cell Changes</title>
            <link>http://www.medworm.com/index.php?rid=2349515&amp;cid=t_140381_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2009%2F04%2F15%2Fstanford-researchers-harness-nanoparticles-to-track-cancer-cell-changes%2F</link>
            <description>&amp;#8220;A new imaging technology could give scientists the ability to simultaneously measure as many as 100 or more distinct features in or on a single cell. In a disease such as cancer, that capability would provide a much better picture of what&amp;#8217;s going on in individual tumor cells. A Stanford University School of Medicine team [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2349515</comments>
            <pubDate>Wed, 15 Apr 2009 21:38:07 +0100</pubDate>
            <guid isPermaLink="false">2349515</guid>        </item>
        <item>
            <title>Ovarian Cancers Detected Early May Be Less Aggressive</title>
            <link>http://www.medworm.com/index.php?rid=2299064&amp;cid=t_140381_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2009%2F03%2F24%2Fovarian-cancers-detected-early-may-be-less-aggressive%2F</link>
            <description>&amp;#8220;The biology of ovarian cancers discovered at an early stage may render them slower growing and less likely to spread than more aggressive cancers, which typically are discovered in an advanced stage, according to a study led by investigators in the Duke Comprehensive Cancer Center.  This finding has implications for the question of whether screening [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2299064</comments>
            <pubDate>Wed, 25 Mar 2009 05:27:59 +0100</pubDate>
            <guid isPermaLink="false">2299064</guid>        </item>
        <item>
            <title>Routine Screening for Hereditary Breast and Ovarian Cancer Recommended By ACOG &amp; SGO</title>
            <link>http://www.medworm.com/index.php?rid=2299065&amp;cid=t_140381_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2009%2F03%2F24%2Froutine-screening-for-hereditary-breast-and-ovarian-cancer-recommended-by-acog-sgo%2F</link>
            <description>Evaluating a patient&amp;#8217;s risk of hereditary breast and ovarian cancer syndrome is an important first step in cancer prevention and early detection and should be a routine part of ob-gyn practice. Those who are likely to have the syndrome should be referred for further assessment to a clinician with expertise in genetics, according to a [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2299065</comments>
            <pubDate>Wed, 25 Mar 2009 03:55:32 +0100</pubDate>
            <guid isPermaLink="false">2299065</guid>        </item>
        <item>
            <title>Dedicated cancer centers trigger rising health costs</title>
            <link>http://www.medworm.com/index.php?rid=1856098&amp;cid=t_140381_131_f&amp;fid=34989&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FGeneticsHealth%2F%7E3%2F6NmI6udJ9CM%2F</link>
            <description>Here where I live, there are several prestigious hospitals with dedicated cancer care centers. At the Johns Hopkins Hospital alone, the Kimmel Cancer Center boasts of the most innovative and advanced therapies in the world. It is complete and self-sufficient such that patients don&amp;#8217;t even have to cross the street to get tests or treatments. Everything is inside one building. The Cancer Center also comes with its own family and patient services, including a Cancer Counseling Center, survivors and palliative care programs, and two residences for patients traveling from out-of-town to receive treatment.
This is happening across the other 40 cancer centers that were designed by the National Canter Institute. As one doctor said, &amp;#8220;We don&amp;#8217;t want to see a patient traveling 200 mil...</description>
            <author>Genetics and Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1856098</comments>
            <pubDate>Tue, 07 Oct 2008 06:48:50 +0100</pubDate>
            <guid isPermaLink="false">1856098</guid>        </item>
        <item>
            <title>MK-0457 Alone and in Combination With Docetaxel Inhibits Ovarian Cancer Growth In Vivo</title>
            <link>http://www.medworm.com/index.php?rid=1773566&amp;cid=t_140381_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2008%2F09%2F07%2Fmk-0457-alone-and-in-combination-with-docetaxel-inhibits-ovarian-cancer-growth-in-vivo%2F</link>
            <description>&amp;#8230;[T]he [M.D. Anderson Cancer Center &amp;#38; Baylor College of Medicine] researchers concluded that [Aurora kinase] AK inhibition [produced by MK-0457] significantly reduces ovarian cancer tumor burden and cell proliferation, and increases tumor cell apoptosis in preclinical ovarian cancer mouse models. The researchers noted that the role of Aurora kinase inhibition in ovarian cancer merits further [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1773566</comments>
            <pubDate>Mon, 08 Sep 2008 00:49:39 +0100</pubDate>
            <guid isPermaLink="false">1773566</guid>        </item>
        <item>
            <title>Imatinib &amp; Docetaxel Produce Modest Response Against Recurrent Platinum Resistant/Refractory Ovarian Cancer</title>
            <link>http://www.medworm.com/index.php?rid=1727796&amp;cid=t_140381_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2008%2F08%2F21%2Fimatinib-docetaxel-produce-modest-response-against-recurrent-platinum-resistantrefractory-ovarian-cancer%2F</link>
            <description>A combination of imatinib mesylate (Gleevec®) and docetaxel (Taxotere®) produced only a modest response in patients with recurrent, platinum-resistant or refractory ovarian cancer, according to the results of a Phase II clinical trial conducted by the Hoosier Oncology Group at Indiana University Cancer Center.

Background
A combination of imatinib mesylate (Gleevec®) and docetaxel (Taxotere®) produced only a [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1727796</comments>
            <pubDate>Fri, 22 Aug 2008 06:58:19 +0100</pubDate>
            <guid isPermaLink="false">1727796</guid>        </item>
        <item>
            <title>Working Smarter, Not Harder: Use of Anti-Estrogen Therapy to Battle Recurrent Ovarian Cancer</title>
            <link>http://www.medworm.com/index.php?rid=1727798&amp;cid=t_140381_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2008%2F08%2F18%2Fworking-smarter-not-harder-anti-estrogen-therapy-to-battle-recurrent-ovarian-cancer%2F</link>
            <description>The Gynecologic Oncology department of the University of Texas, M.D. Anderson Cancer Center took a page out of the breast cancer treatment &amp;#8220;playbook,&amp;#8221; and conducted a single institution Phase II clinical trial using letrozole (Femara®) to treat recurrent, platinum and taxane resistant, high-grade cancer of the ovary and peritoneum. &amp;#8230;The trial investigators concluded that 26% [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1727798</comments>
            <pubDate>Tue, 19 Aug 2008 03:28:31 +0100</pubDate>
            <guid isPermaLink="false">1727798</guid>        </item>
        <item>
            <title>Non-Platinum Topotecan Drug Combination Therapy Provides No Survival Advantage Over Topotecan Monotherapy</title>
            <link>http://www.medworm.com/index.php?rid=1727804&amp;cid=t_140381_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2008%2F07%2F29%2Fnon-platinum-topotecan-drug-combination-therapy-provides-no-survival-advantage-over-topotecan-monotherapy%2F</link>
            <description>&amp;#8220;In women with recurrent ovarian cancer, treatment with topotecan along with etoposide or gemcitabine offers no survival advantage over topotecan monotherapy, German and Austrian researchers report in the July 1st issue of the Journal of Clinical Oncology.&amp;#8221;

&amp;#8220;In women with recurrent ovarian cancer, treatment with topotecan along with etoposide or gemcitabine offers no survival advantage over [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1727804</comments>
            <pubDate>Tue, 29 Jul 2008 18:33:33 +0100</pubDate>
            <guid isPermaLink="false">1727804</guid>        </item>
        <item>
            <title>Cellphone Use, Brain Cancer and UPMC Cancer Center Chief’s Advisory</title>
            <link>http://www.medworm.com/index.php?rid=1652628&amp;cid=t_140381_136_f&amp;fid=36051&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F344938741%2F</link>
            <description>Wednesday, 23 July 2008 is the day the UPMC Cancer Center and University of Pittsburgh Cancer Institute Director Dr. Ronald Herberman is to issue an advisory (pdf file link of the memorandum) on the possible health risks of cellphone use.
&amp;#8220;Recently I have become aware of the growing body of literature linking long-term cell phone use to possible adverse health effects including cancer.
Although the evidence is still controversial, I am convinced that there are sufficient data to warrant issuing an advisory to share some precautionary advice on cell phone use.&amp;#8221;
The advisory suggests certain measures to limit exposure to electromagnetic radiation emitted by the devices, such as shortening the length of conversations or keeping the phones away from the head by text messaging or us...</description>
            <author>Cancer Commentary</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1652628</comments>
            <pubDate>Thu, 24 Jul 2008 20:00:57 +0100</pubDate>
            <guid isPermaLink="false">1652628</guid>        </item>
        <item>
            <title>From Zero to Hero:  HMGB1 Protein Found to Promote DNA Repair, Prevents Cancer</title>
            <link>http://www.medworm.com/index.php?rid=1727806&amp;cid=t_140381_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2008%2F07%2F23%2Ffrom-zero-to-hero-hmgb1-protein-found-to-promote-dna-repair-prevents-cancer%2F</link>
            <description>&amp;#8220;An abundant chromosomal protein [HMGB1] that binds to damaged DNA prevents cancer development by enhancing DNA repair, researchers at The University of Texas M. D. Anderson Cancer Center report online this week in the Proceedings of the National Academies of Science.”

“An abundant chromosomal protein that binds to damaged DNA prevents cancer development by enhancing DNA [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1727806</comments>
            <pubDate>Wed, 23 Jul 2008 20:42:04 +0100</pubDate>
            <guid isPermaLink="false">1727806</guid>        </item>
        <item>
            <title>TP53 Gene Mutation Found in 80% of High Grade Ovarian Serous Carcinomas; TP53 Not Directly Involved In The Development of Drug Resistance</title>
            <link>http://www.medworm.com/index.php?rid=1727808&amp;cid=t_140381_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2008%2F07%2F21%2Ftp53-gene-mutation-found-in-80-of-high-grade-ovarian-serous-carcinomas-tp53-not-directly-involved-in-the-development-of-drug-resistance%2F</link>
            <description>“&amp;#8230; [T]he [Johns Hopkins] research team concluded that the frequency of TP53 gene mutations using purified tumor DNA from ovarian serous carcinomas was 80.3%, which is much higher than previously reported in the medical literature. Furthermore, the research team found that TP53 is not directly involved in the development of drug resistance in high-grade ovarian [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1727808</comments>
            <pubDate>Tue, 22 Jul 2008 05:42:32 +0100</pubDate>
            <guid isPermaLink="false">1727808</guid>        </item>
        <item>
            <title>M.D. Anderson Identifies TG2 As a Potential Target in Chemo-Resistant Ovarian Cancer</title>
            <link>http://www.medworm.com/index.php?rid=1727810&amp;cid=t_140381_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2008%2F07%2F15%2Fmd-anderson-identifies-tg2-as-a-potential-target-in-chemo-resistant-ovarian-cancer%2F</link>
            <description>“Scientists from The University of Texas M. D. Anderson Cancer Center have found overexpression of tissue type transglutaminase (TG2) in ovarian cancer is associated with increased tumor cell growth and adhesion, resistance to chemotherapy and lower overall survival rates. When researchers targeted and silenced TG2 in animal models, cancer progression was reversed, suggesting the protein [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1727810</comments>
            <pubDate>Tue, 15 Jul 2008 19:48:53 +0100</pubDate>
            <guid isPermaLink="false">1727810</guid>        </item>
        <item>
            <title>Anderson Network’s 20th Anniversary Patient and Caregiver Conference</title>
            <link>http://www.medworm.com/index.php?rid=1577512&amp;cid=t_140381_136_f&amp;fid=36051&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F327218954%2F</link>
            <description>What:  Anderson Network&amp;#8217;s 20th Anniversary Patient and Caregiver Conference: Living Fully With and Beyond Cancer Conference
When:  September 4 - 6, 2008
Where:  Houston Marriott Westchase
This year&amp;#8217;s theme is &amp;#8220;Live, Reach, Celebrate&amp;#8221; where Gerald McRaney will be the keynote speaker.
Gerald McRaney has played a farmer and a hit man, an old West gunfighter and a corrupt Southern sheriff, as well as his popular TV roles as a private investigator in &amp;#8220;Simon and Simon&amp;#8221; and a no-nonsense military man with children in &amp;#8220;Major Dad.&amp;#8221;
But the role he recently faced at The University of Texas M. D. Anderson Cancer Center - lung cancer patient - wasn&amp;#8217;t one for which he had studied or auditioned.
This conference is open to all cancer patients and t...</description>
            <author>Cancer Commentary</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1577512</comments>
            <pubDate>Sat, 05 Jul 2008 07:25:48 +0100</pubDate>
            <guid isPermaLink="false">1577512</guid>        </item>
        <item>
            <title>‘Caring For The Caregiver’ Program From Moffitt</title>
            <link>http://www.medworm.com/index.php?rid=1478254&amp;cid=t_140381_136_f&amp;fid=36051&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F300561933%2F</link>
            <description>What: ‘Caring For The Caregiver’ Program
When: 10 a.m. to 3 p.m. Saturday, June 28
Where: Stabile Research Building at Moffitt Cancer Center, 12902 Magnolia Drive (Tampa, Florida)
Moffitt Cancer Center&amp;#8217;s ‘Caring For The Caregiver’ Program is a free education and support program for family cancer caregivers which will be facilitated by Moffitt professionals: Miriam Innocenti (clinical social worker), Jill Blair (nurse practitioner) and Heather Bell (registered dietitian) &amp;#8212; and is open to anyone caring for a cancer patient.
Important notes: Light breakfast and lunch are provided. Registration begins at 9:30 a.m. the day of the program. Reservations are required. Please call 1-888-MOFFITT (1-888-663-3488) by June 24.
[Thanks a lot to Patricia Kim of Moffitt for the hat tip...</description>
            <author>Cancer Commentary</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1478254</comments>
            <pubDate>Thu, 29 May 2008 13:50:13 +0100</pubDate>
            <guid isPermaLink="false">1478254</guid>        </item>
        <item>
            <title>March 2008: Moffitt Dietitians Celebrate National Nutrition Month</title>
            <link>http://www.medworm.com/index.php?rid=1286491&amp;cid=t_140381_136_f&amp;fid=36051&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F247502858%2F</link>
            <description>For the Moffitt Cancer Center&amp;#8217;s Department of Nutrition and their Dietitians, March is a month-long celebration of National Nutrition Month.
Together with the other medical disciplines, Dietitians help in providing quality care and comprehensive medical nutrition therapy, including:

Prevention and treatment of malnutrition
Counseling on diet and cancer prevention
Counseling on dietary supplements
Provision of tube-feeding recommendations
Food safety guidance for patients with decreased immunity

The month-long observance of nutrition is geared towards Moffitt patients and employees.
Spot Moffitt dietitians wearing pink on March 10, Registered Dietitian Day. Registered dietitians have degrees in nutrition, dietetics, public health or related fields, and most have a master’s degree....</description>
            <author>Cancer Commentary</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1286491</comments>
            <pubDate>Fri, 07 Mar 2008 17:22:45 +0100</pubDate>
            <guid isPermaLink="false">1286491</guid>        </item>
        <item>
            <title>Sloan-Kettering Booted CME To Be ‘Squeaky Clean’</title>
            <link>http://www.medworm.com/index.php?rid=1222433&amp;cid=t_140381_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F233121262%2F</link>
            <description>When Memorial Sloan-Kettering Cancer Center in New York City stopped accepting commercial support for its continuing medical education activities last January, many at the institution had their doubts that the program would survive, writes Meetings Net. Most of the staff was surprised at the decision, since participants hadn&amp;#8217;t reported perceiving commercial bias in Sloan-Kettering programs.
“Our staff was very worried that this would deep-six the CME program,” says Thomas Fahey senior vp of the clinical program development at MSKCC, and chairman of the CME committee. But &amp;#8220;we really needed to be squeaky clean and certain that there was no commercial support for our CME activities that could be construed as influencing the program.”
One year later, CME at Memorial Sloan-Ket...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1222433</comments>
            <pubDate>Mon, 11 Feb 2008 12:51:11 +0100</pubDate>
            <guid isPermaLink="false">1222433</guid>        </item>
        <item>
            <title>Participants to Advanced Liver Cancer Study, Wanted by Moffitt</title>
            <link>http://www.medworm.com/index.php?rid=1141024&amp;cid=t_140381_136_f&amp;fid=36051&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F214242047%2F</link>
            <description>The Moffitt Cancer Center in Tampa, Florida is seeking patients who have primary liver cancer (hepatocellular carcinoma) that has spread to other organs or is too advanced to be treated by surgery and must have had prior chemotherapy treatments.
The said patients are being recruited by Moffitt for the phase II study of the oral medication AZD6244 &amp;#8212; an experimental anti-cancer drug that may stop the growth of cancer cells and is designed to block the pathway of a protein called MEK (important for cell survival).
According to Dr. Chris R. Garrett, principal investigator with Moffitt’s Gastrointestinal Oncology program:
“There’s no cure for advanced liver cancer that’s not amenable to surgery. We’re looking for a novel therapy to improve the outcome for patients with the disea...</description>
            <author>Cancer Commentary</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1141024</comments>
            <pubDate>Thu, 10 Jan 2008 07:14:45 +0100</pubDate>
            <guid isPermaLink="false">1141024</guid>        </item>
        <item>
            <title>Moffitt is Looking for Green Tea Study Participants</title>
            <link>http://www.medworm.com/index.php?rid=1058460&amp;cid=t_140381_136_f&amp;fid=36051&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F192312880%2F</link>
            <description>We know how green tea has become popular for its anti-cancer ingredients.
Now, Moffitt Cancer Center is looking for volunteers/participants in a green tea study:
Moffitt Cancer Center is looking to recruit and treat 240 men and evaluate safety and effectiveness of Polyphenon E, a drug developed from green tea, in preventing the progression of early signs of prostate cancer.
The goal is to also assess if Polyphenon E reduces urinary tract symptoms that men experience with this condition.
The following male participants are needed:

between the ages of 30 and 80
have had a biopsy-proven high-grade prostatic intraepithelial neoplasia (HGPIN)
have no prior history of other cancers (other than nonmelanoma skin cancer)
have no history of liver disease
have the ability to take the study drug and ...</description>
            <author>Cancer Commentary</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1058460</comments>
            <pubDate>Thu, 29 Nov 2007 10:21:05 +0100</pubDate>
            <guid isPermaLink="false">1058460</guid>        </item>
        <item>
            <title>November Is Pancreatic Cancer Awareness Month</title>
            <link>http://www.medworm.com/index.php?rid=1033657&amp;cid=t_140381_136_f&amp;fid=36051&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F186080066%2F</link>
            <description>Pancreatic cancer or cancer of the pancreas doesn’t normally show signs or symptoms until it is too late – making it the fourth leading cause of cancer deaths in the U.S.
November is Pancreatic Cancer Awareness Month.
Moffitt Cancer Center’s Gastrointestinal Oncology Program has an early detection and screening program for pancreatic cancer. This program is the only one of its kind in the Southeast, says Dr. Mokenge P. Malafa, head of the division of Gastrointestinal Oncology. Moffitt doctors and researchers are recruiting for this program and several other innovative clinical trials in pancreatic cancer.
Dr. Jason Klapman, an endoscopic oncologist at Moffitt, is the principal investigator of this screening trial targeting patients at high risk of developing pancreatic cancer. Once p...</description>
            <author>Cancer Commentary</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1033657</comments>
            <pubDate>Sat, 17 Nov 2007 02:30:32 +0100</pubDate>
            <guid isPermaLink="false">1033657</guid>        </item>
        <item>
            <title>Up And Down The Ladder… Job Changes</title>
            <link>http://www.medworm.com/index.php?rid=923807&amp;cid=t_140381_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F164662485%2F</link>
            <description>Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. Here are some of the latest moves…
Wolters Kluwer Health names Cathy Betz as vp, government affairs;
Amira Pharmaceuticals named Hari Kumar chief business officer;
Pfizer hired Tanya Clemons as vp and chief talent officer;
Mylan appointed Greg Sheldon as global chief information officer;
Mylan also named Dave Lillback as sr vp and global head of HR;
Mylan taps Brian Byala as sr vp and treasurer;
Glaxo names Roy Anderson a non-executive director and board member;
Kendle named Ken Hintze vp, global cli...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=923807</comments>
            <pubDate>Wed, 03 Oct 2007 11:38:18 +0100</pubDate>
            <guid isPermaLink="false">923807</guid>        </item>
        <item>
            <title>On cancer, waiting, and walking away</title>
            <link>http://www.medworm.com/index.php?rid=822705&amp;cid=t_140381_87_f&amp;fid=34865&amp;url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F08%2F26%2Fon-cancer-waiting-and-walking-away%2F</link>
            <description>Filed under: Cancer SurvivorsWalking into my cancer center waiting room is one of my most sobering experiences. I enter this room -- jam-packed full of men, women, and children -- every three months for a breast cancer follow-up. It never gets easier. It always startles me, stirs my emotions, makes me realize how so many people are touched by such a treacherous and all-consuming disease. The fact that I sit in this room, that I am one of these many people, still doesn't seem real.It's been almost three years since I got a phone call from a surgeon declaring, &quot;You have cancer.&quot; I didn't believe it then. Even after all I've been through -- surgery, chemotherapy, radiation, and more -- I hardly believe it now. But it's real. I have scars and new hair and a whole new set of worries to prove it...</description>
            <author>The Cancer Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=822705</comments>
            <pubDate>Sun, 26 Aug 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">822705</guid>        </item>
        <item>
            <title>Brain cancer patients treated with faulty radiation machines</title>
            <link>http://www.medworm.com/index.php?rid=752808&amp;cid=t_140381_87_f&amp;fid=34865&amp;url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F07%2F24%2Fbrain-cancer-patients-treated-with-faulty-radiation-machines%2F</link>
            <description>Filed under: Brain Cancer, Daily news, RadiationTomorrow I report for one of my six-month radiation follow-ups. My radiation oncologist will review how I've fared for the past two years since my left breast was zapped, day after day, week after week, in an aggressive attempt to keep cancer from returning to the same local area where it first reared its ugly head. How horrified I would be if I learned the machines used to treat my cancer were faulty, that they did not in fact do anything aggressive, that they were essentially ineffective.Hundreds of brain cancer patients may be hearing this horrific news, now that malfunctioning machines have been ordered shut down following a manufacturer's warning.Brainlab of Munich, Germany claims a small targeting error occurred with their machines but ...</description>
            <author>The Cancer Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=752808</comments>
            <pubDate>Tue, 24 Jul 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">752808</guid>        </item>
        <item>
            <title>Post-mastectomy clothing offers perfect fit</title>
            <link>http://www.medworm.com/index.php?rid=658838&amp;cid=t_140381_87_f&amp;fid=34865&amp;url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F06%2F05%2Fpost-mastectomy-clothing-offers-perfect-fit%2F</link>
            <description>Filed under: Breast Cancer, Products, Cancer SurvivorsJacqueline, a clever and crafty breast cancer survivor made this shirt -- pictured at right -- especially for the 2006 Susan G. Komen walk in Central Park. She didn't like the over-sized, over-advertised shirts passed out to the masses, so she designed her own. Notice the songbird stripe on the right side of the shirt? This seamstress renovated the piece to create visual balance for women who have lost a breast and wish to forgo mastectomy and prostheses.Jacqueline, who has named her clothing line Rhea Belle, had a right-side mastectomy in January 2004. She knew she would leave her body as is, but her existing wardrobe didn't &quot;fit&quot; her new shape. When she realized she could either accept her changed architecture or camouflage it, she ch...</description>
            <author>The Cancer Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=658838</comments>
            <pubDate>Tue, 05 Jun 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">658838</guid>        </item>
        <item>
            <title>Oakland A's Nick Swisher shares hair for cancer cause</title>
            <link>http://www.medworm.com/index.php?rid=629105&amp;cid=t_140381_87_f&amp;fid=34865&amp;url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F05%2F21%2Foakland-as-nick-swisher-shares-hair-for-cancer-cause%2F</link>
            <description>Filed under: Daily news, SportsOakland Athletics center fielder Nick Swisher appeared at Saturday evening's pregame event wearing three ponytails. Prepared to donate his locks to the Pantene Beautiful Lengths non-profit campaign, Swisher said just before his ponytails were snipped, &quot;I feel like Pippi Longstocking. I look so goofy right now. But if I can make a difference in one or two women's lives, it's worth it.&quot;Swisher's father -- major league baseball player Steve Swisher -- did the cutting honors. And it was fitting the two men were in on this endeavor together because Swisher's grandmother -- his dad's mother -- died from brain cancer two years ago.&quot;The initial idea was out of respect for my mom -- but the second thing is: It's time for a haircut,'' Steve Swisher said. &quot;I'm so proud ...</description>
            <author>The Cancer Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=629105</comments>
            <pubDate>Mon, 21 May 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">629105</guid>        </item>
        <item>
            <title>More risk factors added to breast cancer list</title>
            <link>http://www.medworm.com/index.php?rid=481866&amp;cid=t_140381_87_f&amp;fid=34865&amp;url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F03%2F19%2Fmore-risk-factors-added-to-breast-cancer-list%2F</link>
            <description>Filed under: Breast Cancer, Prevention, Daily newsSimply being female puts all women at risk for breast cancer. That and age, race, family history, personal history, genetic make-up, when they had children, when they reach menopause, and a whole host of other possible factors.Now U.S. doctors are officially calling body mass index, breast density, and alcohol consumption predictors of the disease, says Therese Bevers, medical director of the Cancer Prevention Center, at the University of Texas M.D. Anderson Cancer Center in Houston.Bevers helped write updated guidelines for the prevention of breast cancer and presented them at the 12th annual National Comprehensive Cancer Network in Hollywood, Florida on Friday. The guidelines, featuring the revised list of risk factors, also offer treatme...</description>
            <author>The Cancer Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=481866</comments>
            <pubDate>Mon, 19 Mar 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">481866</guid>        </item>
    </channel>
</rss>

